There are many ways attempt to treat CS-AKI, including EPO therapy, mesenchymal stem cell therapy, alpha-1-acid glycoprotein therapy, etc. [4, 26, 27, 55, 56]. This evidence concerns the gene ORM1 and Cowden syndrome 1.